Angiotensin-converting enzyme gene polymorphism in patients with minimal-change nephrotic syndrome and focal segmental glomerulosclerosis

Nephron

Volumn 77, Issue 4, 1997, Pages 471-473

  Lee, Dae Yeol ^a   Kim, Won ^a   Kangm, Sung Kyew ^a   Kohm, Gou Young ^a   Park, Sung Kwang ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Angiotensin converting enzyme; Focal segmental glomerulosclerosis; Gene polymorphism; Minimal change nephrotic syndrome

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DNA POLYMORPHISM; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR; STEROID THERAPY;

EID: 0030829905     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190326     Document Type: Article

References (20)

1. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin-I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
2. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotcnsin-l-convcrting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990:86: 1343-1346.
3. Costerouse O, Allegrini J, Lopez M, Alhene-Gelas F: Angiotensin I converting enzyme in the human circulating mononuclear cells: Genetic polymorphism of expression in T lymphocyte. Biochem J 1993:290:33-40.
4. Raynolds MV, Bristoe MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MB: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993;342:1073-1075.
5. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alene-Gelas F, Soubrier F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644.
6. Marian AJ, Yu QT, Workman R, Greve G, Roberts R: Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993; 342:1085-1086.
7. Harden PN, Oolin G, Rowe PA, Mcilroy JH, Boulton-Jones M, Stuart R, Rodger C, Junor BJR: Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 1995;345:1540-1542.
8. Yoshida H, Mitarai T, Kawamura T, Kilajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995;96:2162-2169.
9. Yorioka T, Suehiro T, Yasuoka N, Hashimoto K, Kawada M: Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA ncphropathv. Clin Nephrol 1995:44:80-85.
10. Gaciong ZA, Religa P, Placha G, Rell K, Paczek L: ACE genotype and progression of IgA nephropathy. Lancet 1995;346:570-571.
11. Kawasaki ES: Sample preparation from blood, cells, and other fluids; in Michael A, Gelfand DH, Sninsky JJ, White TJ (eds): PCR Protocols: A Guide to Methods and Applications. San Diego. Academic Press, 1990, pp 146-152.
12. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group: The effects of angiotensin-converting enzyme inhibition of diabetic ncphropathv. N Engl J Med 1993:329: 1456-1462.
13. Kasiskc BL, Kalil RSN, Ma JZ, Liao M, Keane WF: Effects of antihypcrtensive therapy on the kidney in patients with diabetes: A metaregression analysis. Ann Intern Med 1993; 118: 129-138.
14. Schmidt A, Kicner HP, Barnas U, Arias I, Illievich A, Auinger M, Graninger W, Kaider A, Gert M: Angiotensin-converting enzyme polymorphism patients with terminal renal failure. J Am Soc Nephrol 1996;7:314-317.
15. Schmidt S, Schone N, Ritz E: Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int 1995;47:1176-1181.
16. Nomura H, Koni I, Michishita Y, Morisc T, Takeda R: Angiotensin converting enzyme gene polymorphism in hemodialysis patients. Lancet 1994;343:482-483.
17. Yoshida H, Kon V, Ichikawa I: Polymorphisms of the renin-angiotensin system genes in progressive renal diseases. Kidney Int 1996:50: 732-744.
18. Wolf G, Neilson EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993:3:1531-1540.
19. Fogo A, Hawkins EP, Berry PL, Glick AD, Chiang ML, MacDonell RC, Ichikawa I: Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerulosclerosis. Kidney Int 1990:38:115-123.
20. Wolf G, Haberstroh U, Neilson EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 1992; 140:95-107.